Director, WW Medical Cardiovascular & Immunology, Portfolio Strategy & Business Development at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Ability to effectively and efficiently collaborate with and advise leadership across the WW Medical Immunology organization
Capability to evaluate, assess, design, enhance, and develop long and short-term strategies (1-5 years)
Experience in developing and implementing comprehensive portfolio strategies, including business development and early asset planning
Proficiency in providing medical input and perspective for identifying and evaluating new opportunities such as partnerships, acquisitions, and licensing agreements
Skills in leading portfolio-level strategic initiatives, including global advisory boards and KOL engagements
Expertise in gathering insights to guide development decisions, target product profile creation, and commercialization strategies
Ability to provide strategic insights and recommendations based on external and macro trends in healthcare and immunology
Competence in strategically managing budgets, resource allocation, and project prioritization
Strong collaboration skills with R&D, Commercial, Regulatory, and other functions
Ability to foster a culture of collaboration and innovation
Experience integrating medical perspective into commercialization and development strategies
Proficiency in building and maintaining relationships with internal and external stakeholders, including KOLs, partners, and thought leaders
Capability to represent the organization at industry conferences and meetings

Responsibilities

Effectively and efficiently collaborate with and advise leadership across the WW Medical Immunology organization to evaluate, assess, design, enhance, and develop long and short-term strategies (1-5 years)
Collaborate with leaders across the Immunology organization to evaluate and assess long and short-term strategies while exploring various business development opportunities as a cross-functional team
Develop and implement comprehensive portfolio strategies, including business development and early asset planning for the Immunology division, aligning with overall business goals and market trends
Provide medical input and perspective to identify and evaluate new opportunities, including partnerships, acquisitions, and licensing agreements, to expand the immunology portfolio
Lead portfolio-level strategic initiatives such as global advisory boards and engagements with KOLs to drive insights shaping Portfolio Strategic Plans within the immunology space, identifying trends and unmet needs
Gather insights to guide development decisions, target product profile creation, and commercialization strategies that best meet the needs of our patients within the immunology space
Provide strategic insights and recommendations to senior leadership based on external and macro trends in the healthcare environment and the immunology space
Strategically manage budgets in alignment with departmental objectives, identifying strategic activities based on business priorities, and ensuring optimal resource allocation and prioritization of projects
Collaborate with R&D, Commercial, Regulatory, and other key functions to ensure seamless execution of portfolio strategies
Foster a culture of collaboration and innovation across teams to drive the success of the immunology portfolio
Partner with Commercial and Research & Development to integrate the medical perspective into the commercialization process and development strategy
Build and maintain relationships with key internal and external stakeholders, including key opinion leaders, potential partners, industry experts, and thought leaders
Represent the organization at industry conferences and meetings, connecting and collaborating in the external environment to understand evolving treatment landscapes, identify medical insights, and share findings internally with development

Skills

Portfolio Strategy

Business Development

Medical Strategy

Scientific Strategy

Immunology

Cardiovascular

Strategic Planning

Cross-functional Collaboration

R&D Collaboration

Commercial Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free